Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are antigenically distinct
Tóm tắt
The emergence and rapid spread of SARS-CoV-2 variants may affect vaccine efficacy substantially. The Omicron variant termed BA.2, which differs substantially from BA.1 based on genetic sequence, is currently replacing BA.1 in several countries, but its antigenic characteristics have not yet been assessed. Here, we used antigenic cartography to quantify and visualize antigenic differences between early SARS-CoV-2 variants (614G, Alpha, Beta, Gamma, Zeta, Delta, and Mu) using hamster antisera obtained after primary infection. We first verified that the choice of the cell line for the neutralization assay did not affect the topology of the map substantially. Antigenic maps generated using pseudo-typed SARS-CoV-2 on the widely used VeroE6 cell line and the human airway cell line Calu-3 generated similar maps. Maps made using authentic SARS-CoV-2 on Calu-3 cells also closely resembled those generated with pseudo-typed viruses. The antigenic maps revealed a central cluster of SARS-CoV-2 variants, which grouped on the basis of mutual spike mutations. Whereas these early variants are antigenically similar, clustering relatively close to each other in antigenic space, Omicron BA.1 and BA.2 have evolved as two distinct antigenic outliers. Our data show that BA.1 and BA.2 both escape vaccine-induced antibody responses as a result of different antigenic characteristics. Thus, antigenic cartography could be used to assess antigenic properties of future SARS-CoV-2 variants of concern that emerge and to decide on the composition of novel spike-based (booster) vaccines.
Từ khóa
Tài liệu tham khảo
World Health Organization “Numerical data from WHO coronavirus (COVID-19) dashboard”; https://covid19.who.int.
World Health Organization “Tracking SARS-Cov-2 variants ” 2022 https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/ [accessed 10 February 2022].
National Center for Immunization and Respiratory Diseases (NCIRD) Division of viral diseases in CDC COVID-19 Science Briefs (Centers for Disease Control and Prevention 2020).
W. R. Gallaher “Omicron is a multiply recombinant set of variants that have evolved over many months ” 2022; https://virological.org/t/omicron-is-a-multiply-recombinant-set-of-variants-that-have-evolved-over-many-months/775 [accessed 18 February 2022].
Freunde von GISAID “GISAID - hCov19 variants ” 2022; https://www.gisaid.org/hcov19-variants [accessed 18 February 2022].
M. M. Lamers A. Z. Mykytyn T. I. Breugem N. Groen K. Knoops D. Schipper R. van Acker P. B. van den Doel T. Bestebroer C. D. Koopman C. Reusken M. J. Muraro C. H. GeurtsvanKessel M. E. van Royen P. J. Peters J. Zhang B. L. Haagmans SARS-CoV-2 Omicron efficiently infects human airway but not alveolar epithelium. bioRxiv 2022.01.19.476898 [Preprint]. 20 January 2022. https://doi.org/10.1101/2022.01.19.476898.
S. H. Wilks B. Mühlemann X. Shen S. Türeli E. B. LeGresley A. Netzl M. A. Caniza J. N. Chacaltana-Huarcaya X. Daniell M. B. Datto T. N. Denny C. Drosten R. A. M. Fouchier P. J. Garcia P. J. Halfmann A. Jassem T. C. Jones Y. Kawaoka F. Krammer C. McDanal R. Pajon V. Simon M. Stockwell H. Tang H. van Bakel R. Webby D. C. Montefiori D. J. Smith Mapping SARS-CoV-2 antigenic relationships and serological responses. bioRxiv 2022.01.28.477987 [Preprint]. 28 January 2022. https://doi.org/10.1101/2022.01.28.477987.